Details of the Drug-Related molecule(s) Interaction Atlas

General Information of DTT (ID: TTYRO4F)

Molecule-Related Drug & Molecule List

Molecule-Related Drug List

Molecule Type:

DTT

DTP

DME

Drug Status:

Approved Drug(s)

Clinical Trial Drug(s)

Download the Complete Related Drug List

1 Approved Drug(s) Transported by This DTP

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
Romosozumab	DMFJZN0	Postmenopausal osteoporosis	FB83.11	Approved	[1]
------------------------------------------------------------------------------------

4 Clinical Trial Drug(s) Transported by This DTP

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
UX143	DM89NIB	Osteogenesis imperfecta	LD24.K0	Phase 3	[2]
BPS-804	DMDYZRS	Metabolic bone disease	FB8Y	Phase 2	[3]
LY2541546	DMTVU2Q	Osteoporosis	FB83.0	Phase 2	[4]
AMG 167	DMUETI2	Osteoporosis	FB83.0	Phase 1	[5]
------------------------------------------------------------------------------------

Molecule Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

References

1	Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health Human Services. 2019
2	Clinical pipeline report, company report or official report of Ultragenyx Pharmaceutical
3	WO patent application no. 2010,1001,79, Self-forming gel system for sustained drug delivery.
4	Rat-specific decreases in platelet count caused by a humanized monoclonal antibody against sclerostin. Toxicol Sci. 2012 Feb;125(2):586-94.
5	Osteoporosis - a current view of pharmacological prevention and treatment. Drug Des Devel Ther. 2013; 7: 435-448.